< 生产厂家价格 >

葡萄糖酸钙

葡萄糖酸钙用途

Calcium gluconate是一种矿物质补充剂, 由葡糖酸和石灰或碳酸钙中和制成。

点击显示

葡萄糖酸钙名称

[ CAS 号 ]:
299-28-5

[ 中文名 ]:
葡萄糖酸钙

[ 英文名 ]:
Calcium gluconate

[中文别名 ]:

[英文别名 ]:

Calcium gluconate
D-Gluconic acid,calcium salt
D-Gluconsaeure,Calciumgluconat
EINECS 206-075-8
calglucol
calcicol
Calcium di(D-gluconate)
dragocal
Gluconic acid, calcium salt, D-
Calcisan

葡萄糖酸钙生物活性

[ 描述 ]:

Calcium gluconate是一种矿物质补充剂, 由葡糖酸和石灰或碳酸钙中和制成。

[ 相关类别 ]:

信号通路 >> 其他 >> 其他

研究领域 >> 其他

[相关活性小分子]

葡萄糖酸钙物理化学性质

[ 沸点 ]:
673.6ºC at 760 mmHg

[ 熔点 ]:
195°C

[ 分子式 ]:
C₆H₁₂O_7.1/₂Ca

[ 分子量 ]:
216.20

[ 闪点 ]:
375.2ºC

[ PSA ]:
254.90000

[ 外观性状 ]:
白色结晶粉末或颗粒

[ 储存条件 ]:
库房低温通风干燥

[ 水溶解性 ]:
3.3 g/100mL

葡萄糖酸钙MSDS

详细MSDS(安全技术说明书)

葡萄糖酸钙毒性和生态

CHEMICAL IDENTIFICATION

RTECS NUMBER :: EW2100000

CHEMICAL NAME :: Calcium gluconate

CAS REGISTRY NUMBER :: 299-28-5

LAST UPDATED :: 199701

DATA ITEMS CITED :: 13

MOLECULAR FORMULA :: C12-H22-O14.Ca

MOLECULAR WEIGHT :: 430.42

WISWESSER LINE NOTATION :: QVYQYQYQYQ1Q 2 &-CA-

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Intramuscular

SPECIES OBSERVED :: Human - infant

DOSE/DURATION :: 143 mg/kg

TOXIC EFFECTS :: Skin and Appendages - dermatitis, other (after systemic exposure) Nutritional and Gross Metabolic - body temperature increase

REFERENCE :: JAMAAP JAMA, Journal of the American Medical Association. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1- 1883- Volume(issue)/page/year: 129,347,1945

TYPE OF TEST :: LDLo - Lowest published lethal dose

ROUTE OF EXPOSURE :: Intramuscular

SPECIES OBSERVED :: Human - infant

DOSE/DURATION :: 10 gm/kg

TOXIC EFFECTS :: Brain and Coverings - meningeal changes Lungs, Thorax, or Respiration - fibrosis, focal (pneumoconiosis) Nutritional and Gross Metabolic - body temperature increase

REFERENCE :: JAMAAP JAMA, Journal of the American Medical Association. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1- 1883- Volume(issue)/page/year: 129,347,1945

TYPE OF TEST :: LDLo - Lowest published lethal dose

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 10 gm/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: FRPPAO Farmaco, Edizione Pratica. (Casella Postale 227, 27100 Pavia, Italy) V.8-43 1953-88 For publisher information, see FRMCE8 Volume(issue)/page/year: 26,144,1971

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intravenous

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 950 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,226,1982

TYPE OF TEST :: LDLo - Lowest published lethal dose

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 10 gm/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: FRPPAO Farmaco, Edizione Pratica. (Casella Postale 227, 27100 Pavia, Italy) V.8-43 1953-88 For publisher information, see FRMCE8 Volume(issue)/page/year: 26,144,1971

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intraperitoneal

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 2200 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: JDGRAX Journal of Drug Research. (National Organization for Drug Research and Control, POB 29, Cairo, Egypt) V.2- 1969- Volume(issue)/page/year: 15(1-2),121,1984

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Subcutaneous

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 2890 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: JAPMA8 Journal of the American Pharmaceutical Association, Scientific Edition. (Washington, DC) V.29-49, 1940-60. For publisher information, see JPMSAE. Volume(issue)/page/year: 45,47,1956

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intravenous

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 950 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: TXAPA9 Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- Volume(issue)/page/year: 4,492,1962

TYPE OF TEST :: LDLo - Lowest published lethal dose

ROUTE OF EXPOSURE :: Intravenous

SPECIES OBSERVED :: Mammal - dog

DOSE/DURATION :: 1987 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- Volume(issue)/page/year: 47,183,1933

TYPE OF TEST :: LDLo - Lowest published lethal dose

ROUTE OF EXPOSURE :: Intravenous

SPECIES OBSERVED :: Rodent - guinea pig

DOSE/DURATION :: 1810 mg/kg

TOXIC EFFECTS :: Cardiac - other changes Lungs, Thorax, or Respiration - dyspnea Gastrointestinal - changes in structure or function of salivary glands

REFERENCE :: AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898- Volume(issue)/page/year: 191,44,1971 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOHS - National Occupational Hazard Survey (1974) NOHS Hazard Code - 80373 No. of Facilities: 267 (estimated) No. of Industries: 3 No. of Occupations: 11 No. of Employees: 14905 (estimated) NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - 80373 No. of Facilities: 565 (estimated) No. of Industries: 3 No. of Occupations: 16 No. of Employees: 29060 (estimated) No. of Female Employees: 23111 (estimated)

点击显示

葡萄糖酸钙安全信息

[ 个人防护装备 ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter

[ 危害码 (欧洲) ]:
Xn

[ 风险声明 (欧洲) ]:
20/21/22-36/37/38

[ 安全声明 (欧洲) ]:
S24/25

[ 危险品运输编码 ]:
NONH for all modes of transport

[ WGK德国 ]:
1

[ RTECS号 ]:
EW2100000

[ 海关编码 ]:
2918160000

葡萄糖酸钙上下游产品

葡萄糖酸钙上游产品

葡萄糖酸钙下游产品

葡萄糖酸钙制备

1.淀粉乳用硫酸水解得到葡萄糖液，加石灰乳、营养盐和黑莓菌种子营养液，进行发酵。发酵液加石灰乳中和，过滤，滤液减压浓缩，结晶得粗产品，精制得到葡糖酸钙。

2.淀粉糖化发酵法

点击显示

葡萄糖酸钙海关

[ 海关编码 ]: 2918160000

[ 中文概述 ]:
2918160000. 葡糖酸及其盐和酯. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:30.0%

[ 申报要素 ]: 品名, 成分含量, 用途

[ Summary ]:
2918160000. gluconic acid, its salts and esters. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0%

葡萄糖酸钙文献

Calcium Chloride in Neonatal Parenteral Nutrition Solutions with and without Added Cysteine: Compatibility Studies Using Laser and Micro-Flow Imaging Methodology.

PLoS ONE 10 , e0136894, (2015)

Previous studies of compatibility of calcium chloride (CaCl2) and phosphates have not included particle counts in the range specified by the United States Pharmacopeia. Micro-flow imaging techniques h...

Dietary calcium deficiency and excess both impact bone development and mesenchymal stem cell lineage priming in neonatal piglets.

J. Nutr. 144(12) , 1935-42, (2014)

Optimizing calcium nutrition to maximize bone accretion during growth to prevent fragility fractures later in life has spurred greater interest in calcium nutrition in neonates.The aim of this study w...

Goshajinkigan, a traditional Japanese medicine, prevents oxaliplatin-induced acute peripheral neuropathy by suppressing functional alteration of TRP channels in rat.

J. Pharmacol. Sci. 125(1) , 91-8, (2014)

The acute peripheral neuropathy induced by oxaliplatin treatment occurs very frequently and is aggravated by exposure to cold. Goshajinkigan (GJG), a traditional Japanese (kampo) medicine, was recentl...

更多文献

葡萄糖酸钙

葡萄糖酸钙用途

葡萄糖酸钙名称

葡萄糖酸钙生物活性

葡萄糖酸钙物理化学性质

葡萄糖酸钙MSDS

详细MSDS(安全技术说明书)

葡萄糖酸钙毒性和生态

CHEMICAL IDENTIFICATION

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

葡萄糖酸钙安全信息

葡萄糖酸钙上下游产品

葡萄糖酸钙上游产品

葡萄糖酸钙下游产品

葡萄糖酸钙制备

葡萄糖酸钙海关

葡萄糖酸钙文献

相关化工产品/化学物质：

相关药品：

推荐生产厂家/供应商：

相关化合物